Systems biology meets -omic technologies: novel approaches to biomarker discovery and companion diagnostic development

被引:15
|
作者
Caberlotto, Laura [1 ]
Lauria, Mario [1 ]
机构
[1] Univ Trento, Ctr Computat & Syst Biol COSBI, Microsoft Res, I-38068 Rovereto, Italy
关键词
companion diagnostic; molecular biomarkers; network analysis; systems biology; systems medicine; systems pharmacology; GENE-EXPRESSION; DNA METHYLATION; PERSONALIZED MEDICINE; BIOMEDICAL-RESEARCH; BREAST-CANCER; THERAPY; DISEASE; EPIGENETICS; PHARMACOGENOMICS; CLASSIFICATION;
D O I
10.1586/14737159.2015.975214
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The next generation of biomarkers and companion diagnostics will require the development of technologies capable of conjugating the advances in high-throughput techniques in biology with computational methods. Systems biology is poised to contribute through an integrated view, capturing the complexity of the system, both in terms of a collection of interacting molecular components and also in terms of multiple intersecting views. Following this system-centered view, novel approaches have been developed for the identification of signatures of both disease processes and drug modes of action with the promising perspectives of better diagnosis of disease and of the discovery of more efficacious and safe drugs. The application of systems biology to the development of companion diagnostics is very recent and to date a few pioneering steps have been made in this direction. In this review, we describe the ongoing studies and the potential developments in this area of research.
引用
收藏
页码:255 / 265
页数:11
相关论文
共 50 条
  • [1] Chemistry meets the -omic sciences and systems biology
    Kodadek, T
    Evans, C
    MOLECULAR BIOSYSTEMS, 2005, 1 (01) : 10 - 11
  • [2] SYSTEMS PHARMACOLOGY - SYSTEMS BIOLOGY MEETS DRUG DISCOVERY & DEVELOPMENT
    Lauffenburger, Douglas A.
    DRUG METABOLISM REVIEWS, 2014, 45 : 1 - 1
  • [3] Multi-omic approaches for biomarker discovery in Moyamoya disease
    Gatti, Laura
    Bersano, Anna
    Gorla, Gemma
    Pollaci, Giuliana
    Carrozzini, Tatiana
    Potenza, Antonella
    CLINICAL AND TRANSLATIONAL DISCOVERY, 2024, 4 (02):
  • [4] Systems biology and biomarker discovery
    Rodland, Karin D.
    DISEASE MARKERS, 2010, 28 (04) : 195 - 197
  • [5] Genomic, proteomic, and systems biology approaches in biomarker discovery for multiple sclerosis
    Huizar, Carol Chase
    Raphael, Itay
    Forsthuber, Thomas G.
    CELLULAR IMMUNOLOGY, 2020, 358
  • [6] Global systems biology and statistical spectroscopic approaches to biomarker discovery.
    Nicholson, Jeremy K.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2006, 19 (12) : 1681 - 1681
  • [7] Biomarker discovery and validation:: technologies and integrative approaches
    Ilyin, SE
    Belkowski, SM
    Plata-Salamán, CR
    TRENDS IN BIOTECHNOLOGY, 2004, 22 (08) : 411 - 416
  • [8] Systems biology for diabetic biomarker discovery
    Wu, J.
    FEBS JOURNAL, 2011, 278 : 38 - 38
  • [9] PROTEOMIC APPROACHES FOR NOVEL BIOMARKER DISCOVERY
    Kulasingam, V.
    Makawita, S.
    Diamandis, E. P.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S25 - S25
  • [10] Application of NanoString technologies in companion diagnostic development
    Eastel, Jennifer Mary
    Ka Wai Lam
    Nga Lam Lee
    Wing Yan Lok
    Tsang, Andy Hin Fung
    Pei, Xiao Meng
    Chan, Amanda Kit Ching
    Cho, William Chi Shing
    Wong, Sze Chuen Cesar
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2019, 19 (07) : 591 - 598